China Cord Blood Corp (CO)

[thedivot]

Help me understand the value here. Their 6-mth EPS results were $0.02 (GAAP) or $0.08 (non-GAAP). They talk about 30% growth in subscribers & revenue next year. Yes, it's in China which gives it good potential (especially if they can get more licenses) but it sure is expensive. Even annualizing the non-GAAP EPS of .08 gives .16 and therefore a FP/E of 42 at today's $6.69 share price. That's pretty high for growth of 30%. When so many Chinese other stocks are at ridiculously low P/Es, what's the big appeal of this one?